Ettrup A - Search Results

1

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies.

Smith TR, Spierings ELH, Cady R, Hirman J, Ettrup A, Shen V. Smith TR, et al. Among authors: ettrup a. J Headache Pain. 2021 Nov 25;22(1):143. doi: 10.1186/s10194-021-01360-1. J Headache Pain. 2021. PMID: 34823467 Free PMC article. Clinical Trial.

2

Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study.

Biederman J, Lindsten A, Sluth LB, Petersen ML, Ettrup A, Eriksen HF, Fava M. Biederman J, et al. Among authors: ettrup a. J Psychopharmacol. 2019 Apr;33(4):511-521. doi: 10.1177/0269881119832538. Epub 2019 Mar 7. J Psychopharmacol. 2019. PMID: 30843450 Clinical Trial.

3

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.

Winner PK, McAllister P, Chakhava G, Ailani J, Ettrup A, Krog Josiassen M, Lindsten A, Mehta L, Cady R. Winner PK, et al. Among authors: ettrup a. JAMA. 2021 Jun 15;325(23):2348-2356. doi: 10.1001/jama.2021.7665. JAMA. 2021. PMID: 34128999 Free PMC article. Clinical Trial.

4

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.

McAllister P, Winner PK, Ailani J, Buse DC, Lipton RB, Chakhava G, Josiassen MK, Lindsten A, Mehta L, Ettrup A, Cady R. McAllister P, et al. Among authors: ettrup a. J Headache Pain. 2022 Feb 7;23(1):22. doi: 10.1186/s10194-021-01376-7. J Headache Pain. 2022. PMID: 35130832 Free PMC article. Clinical Trial.

5

Eptinezumab for migraine prevention in patients 50 years or older.

Martin V, Tassorelli C, Ettrup A, Hirman J, Cady R. Martin V, et al. Among authors: ettrup a. Acta Neurol Scand. 2022 Jun;145(6):698-705. doi: 10.1111/ane.13603. Epub 2022 Feb 26. Acta Neurol Scand. 2022. PMID: 35218203 Free PMC article.

6

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2.

Ashina M, McAllister P, Cady R, Hirman J, Ettrup A. Ashina M, et al. Among authors: ettrup a. Cephalalgia. 2022 Jul;42(8):696-704. doi: 10.1177/03331024221077646. Epub 2022 Mar 18. Cephalalgia. 2022. PMID: 35302389 Free PMC article. Clinical Trial.

7

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine.

McAllister P, Kudrow D, Cady R, Hirman J, Ettrup A. McAllister P, et al. Among authors: ettrup a. Cephalalgia. 2022 Sep;42(10):1005-1012. doi: 10.1177/03331024221089567. Epub 2022 Mar 25. Cephalalgia. 2022. PMID: 35332807 Free PMC article. Clinical Trial.

8

Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention.

Lipton RB, Goadsby PJ, Dodick DW, McGinley JS, Houts CR, Wirth RJ, Kymes S, Ettrup A, Østerberg O, Cady R, Ashina M, Buse DC. Lipton RB, et al. Among authors: ettrup a. Headache. 2022 Jun;62(6):690-699. doi: 10.1111/head.14295. Epub 2022 Apr 25. Headache. 2022. PMID: 35466430 Free PMC article. Clinical Trial.

9

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.

Ailani J, McAllister P, Winner PK, Chakhava G, Krog Josiassen M, Lindsten A, Sperling B, Ettrup A, Cady R. Ailani J, et al. Among authors: ettrup a. BMC Neurol. 2022 Jun 3;22(1):205. doi: 10.1186/s12883-022-02714-1. BMC Neurol. 2022. PMID: 35659622 Free PMC article. Clinical Trial.

10

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Ashina M, Lanteri-Minet M, Pozo-Rosich P, Ettrup A, Christoffersen CL, Josiassen MK, Phul R, Sperling B. Ashina M, et al. Among authors: ettrup a. Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5. Lancet Neurol. 2022. PMID: 35716692 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters